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Abstract: Eighty four samples of commercial infant foods in Libya were examined for microbiological quality. Bacillus 
cereus, B. stearothermophilus, B. licheniformis, Staphylococcus xylosus, S.lentus, Enterobacter sakazakii, E. aerogenes 
were isolated from the samples. Over 64.3 % of the samples contained high counts of Bacillus spp ( 2 log10 CFU/g), 
42.9% Staphylococcus spp ( 2 log10 CFU/g) and 26.3% Enterobacteriaceae ( 2 log10 CFU/g). The moulds isolated were 
mainly of the genera, Aspergillus and Penicillium. In relation to antibiotic resistance Bacillus spp showed the highest level 
of resistance to bacittracin (63.6%), ampicillin (54.5%), cephalosporin (36.4%), penicillin (18.1%) and nalidixine acid 
(18.2%). Corresponding values for Staphylococcus spp were bacitracin 60%, erythromycin 30%, penicillin 30%, cepha-
losporin 10%, nalidixic acid 10% and ampicillin 10%, respectively. Enterobacteriaceae strains were resistant to bacitracin 
(100%), erythromycin (62.5%), ampicillin (37.5%), cephalosporin (25%) and nalidixine acid (12.5 %). Bacillus spp, 
Staphylococcus spp and Enterobacteriaceae were susceptible to chloramphenicol, kanamycin, gentamicin and streptomy-
cin.  
Keywords: Infant food, Bacillus spp., enterobacteriaceae, Staphylococcus spp., antimicrobial resistance.  
INTRODUCTION 
Contamination of infant food by microorganisms and 
natural toxins such as enterotoxins and mycotoxins has been 
the most common problem resulting in several outbreaks of 
diseases [1-4]. In most studies reviewed, contamination of 
infant food formula by pathogenic microorganisms at some 
points during production resulted in several outbreaks of 
diseases worldwide. The use of infant formula in developing 
countries has caused higher rates of diarrhoeal morbidity and 
mortality, possibly because contaminated water is often used 
to prepare infant formula and because the high nutrient con-
tents of infant formula provide a good growth medium for 
bacterial pathogens [5]. 
Lehner et al. [6] reported that when reconstituted formula 





 CFU/100 ml. Schmitt et al. [7] reported two 
cases of food poisoning that resulted from the consumption 
of powdered milk products. Muytjens et al. [8] and Forsythe 
[9] reported the isolation of the Enterobacteriaceae from 
powdered infant formula. The Enterobacteriaceae isolated 
included Enterobacter agglomerans, E. cloacae, E. saka-
zakii, Citrobacter koseri and Klebsiella oxytoca.  
In New Zealand, there were four identified cases of E. 
sakazakii infection in premature babies 
_ 
one in 1986, two in 
1991 and one in 2004 have been linked to consumption of 
infant formula [10, 11]. Enterobacter sakazakii causes major  
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infections especially among neonates [2, 12]. Recently the 
Food Standards Agency, UK reported on the presence of E. 
sakazakii in a Ugandan baby food product [13]. 
Improperly stored cereal-based product may also become 
contaminated with fungi and under conditions of high hu-
midity, poor ventilation and warm temperature growth of 
certain fungi may result in the production of toxic substances 
(mycotoxins) which are known to be carcinogenic. Studies 
on occurrence of microorganisms and potential microbial 
metabolites in baby food and feed formula have received 
little attention particularly in developing countries.  
The aim of the present study was to evaluate the micro-
biological contamination of commercial infant food available 
in North Africa and to determine the susceptibility of the 
isolated bacteria against some antibiotics.  
MATERIALS AND METHODS 
Samples and Media 
Eighty four samples of baby food consumed by Libyan 
infants were collected from several local sources including 
retailers, factories and stores. Samples which consisted of 
imported and locally produced products were stored dry at 
room temperature (22 + 2
o
C) and examined to determine 
their level of contamination. The samples contained rice 
flour, wheat flour, mixed grain cereal contained, wheat, rice, 
barley, and oat flour, skimmed milk powder or whole milk 
powder and in various combination. The samples were ex-
amined for bacteria species such as Bacillus spp, Staphylo-
coccus spp, Enterobacteriaceae and fungi. Standard methods 
were used for isolation, enumeration and identification of 
bacteria and fungi [14, 15].  
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Samples were reconstituted in maximum recovery dilu-
ents (MRD). Total aerobic bacterial counts were determined 
using plate count agar. Bacillus cereus was isolated and 
enumerated using Bacillus cereus selective agar (PEMBA) 
and Bacillus cereus agar base. Coliforms and Enterobacte-
riaceae were isolated and enumerated using Violet red bile 
glucose (VRBG) agar. Enterobacter sakazakii was isolated 
by using Chromocult
® 
Enterobacter sakazakii agar. Staphy-
lococcus spp was isolated and enumerated using Baird-
Parker agar. Selective enrichment broth (RV) and XLD were 
used for isolation of Salmonella. spp. Moulds and yeast were 
isolated and enumerated using malt extract agar (MEA) and 
potato dextrose agar (PDA). All media and diluents were 
purchased from Oxoid (Basingstoke, UK).  
Antimicrobial Compounds Tested on Isolates 
The following antimicrobial agents: penicillin, cepha-
losporin, bacitracin, polymxin B, streptomycin, tetracycline 
and gentamicin were purchased from Sigma, (Dorset, UK) 
and their minimum inhibitory concentrations (MIC) evalu-
ated against some of the bacteria isolated.  
Studies on antimicrobial resistance of the isolates were 
carried out with the following antibiotic test discs purchased 
from Oxoid (Basingstoke, UK): penicillin G10 units, cepha-
losporin 30 g, bacitracin 10units, streptomycin 10 g, tetra-
cycline 30 g, gentamicin 10 g, erythromycin 15 g, ampicil-
lin 10 g, chloramphenicol 30 g, kanamycin 10 g and 
naldixic acid 30 g. 
Cultivation, Enumeration and Identification of Microor-
ganisms 
Sterile maximum recovery diluent (225 ml) was added to 
25 g of the sample, and then mixed in a stomacher for 60s. 
The bacteria and fungi present were isolated and enumerated 
by plating out in a serial dilution for each sample in triplicate 
onto PCA, PEMBA, Baird-Parker agar, XLD agar and 
VRBG agar for bacteria and, MEA and PDA for fungi. The 
plates were incubated at 37ºC for 48h and 25ºC for 5 days 
respectively. The results were reported as the percentage of 
the samples positive for each organism.  
Colonies obtained on the culture media were also exam-
ined for the following properties: Gram staining, catalase 
reactions, haemolytic reaction and motility. In addition to 
these tests each isolate was confirmed using the API 20 E, 
API staph and API 50 CH tests (Biomerieux, Basingstoke, 
UK). Fungal isolates were identified according to the method 
described by Samson et al. [15] size, colour and morphology 
of colonies on media were recorded after incubation at 25° C 
for 5 days. 
Inhibition Assays 
Determination of MIC and susceptibility of the isolated 
bacteria to various antibiotics was performed following Na-
tional Committee for Clinical Laboratory Standard recom-
mendations (NCCLS, 1993) [16]. Thirty one bacterial strains 
were used; twenty eight were isolated from the samples and 
three were type cultures used for control purposes (Staphylo-
Table 1. Total Bacterial and Fungal Counts and Occurrence of Bacillus spp., Enterobacteriaceae and Staphylococcus spp. in Infant 
Foods 





Main Ingredients Range log10 
CFU/g of Total 
Count 
Range log10 
CFU/g of Fungi  Bacillus spp. Enterobacteriaceae Staphylococcus 
spp. 
P1 8 Rice flour, maltodextrin.  <1.0 – 3.67 1.0 - 3.67  3 (37.5 % ) ND 4 (50 %) 
P2 3 Rice flour, malt, maltodextrin. <1.0 – 3.43 <1.0 – 2.63 1 (33.3% ) ND ND  
P3 1 Wheat flour, sugar, vegetable. 3.81 3.0 1 (100 %) ND  ND 
P4 5 Cereals with milk. <1.0 – 5.28 <1.0 - 3.3 3 (100 %) ND 2 (40%) 
P5 4 Rice flour. <1.0 – 3.91 <1.0 – 2.52 3 (75%) 2 (50%) 2 (50%) 
P6 7 Wheat flour, banana, skimmed 
milk powder, whole milk 
powder, malt extract, milk fat. 
<1.0 -3.54 <1.0 – 3.4 3 (42.9%) 2 (28.6%) 3 (42.9 %) 
P7 3 Wheat flour, vegetables (carrot, 
tomato, peas, spinach), 
skimmed milk powder, malt 
extract, milk fat. 
<1.0 – 6.43 2.36 – 3.43 2 (67 %) 1 (33.3%) 3(100%) 
P8 7 Wheat flour, corn starch. <1.0 – 3.39 <1.0 – 2.82 4 (57.1 % ) ND ND 
P9 9 Milk, cereal, orange and honey, 
skimmed milk, wheat flour. 
<1.0 – 4.06 <1.0 – 3.32 6 (66.7 %) 5 (55.6%) 6 (66.7%) 
P10 3 Wheat flour, skimmed milk 
powder, banana, malt extract, 
milk fat. 
2.69 – 5.81 2.69 – 3.39 3 (100 %) ND 2 (66.6 %)  
P11 3 Skimmed milk, wheat flour, 
fruit concen-
trates(orange,banana, lemon). 
<1.0 – 3.82 <1.0 – 2.83 2 (66.6 %) 1 (33.3%) 1 (33.3%) 
P12 1 Rice flour. 3.57 2.91 1(100 %)  ND 1 (100 %) 
P13 9 Wheat flour, nuts.  1.89 – 5.58 <1.0 – 3.57 5 (55.6%) 4 (80%) 2 (22.2 %) 
P14 2 Rice flour , nuts. 2.75 – 2.79 2.43 – 2.80 2 (100 %) 1 (50%) 1 (50 %) 
P15 5 Rice flour. 2.44 – 4.41 0.0 – 3.64 3 (60%) 1 (20 %) 1 (20%) 
P16 14 Ground nuts and mixed grains. 2.91 – 5.34 0.0 – 3.43 8 (57.1%) 6 (42.9 %) 6 (42.9 %) 
Total 84    61.9 % 27.4 % 40.5 % 
ND = not detected. 
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coccus aureus, NCTC6571 and E. coli, NCTC9001 obtained 
from the National Collection of Typed Cultures and E. saka-
zakii NCIMB 8272 purchased from the National Collection 
of Industrial and Marine Bacteria Ltd, Aberdeen, Scotland). 
Bacterial isolates were cultivated in nutrient broth at 
35°C for 2 – 5 h until an absorbance of 0.2 was obtained at 
wavelength, 450 nm, and equivalent to cell density of 10
8
 
CFU/ml as described by Carmen et al. [17] with some modi-
fications. Swabs were dipped into standardised bacterial sus-
pension and then streaked in three directions over the surface 
of plate agar and allowed to dry for 5 min before the discs 
(13 mm) and antibiotics were applied. An aliquot of 0.1 ml 
antibiotic was placed onto each disc. The inhibition zones 
(mm) were recorded after incubation at 35 °C for 24 h. 
Data Analyses 
Tests were carried out in triplicates. Colonies were 
counted and expressed as log10 CFU/g. Mean and SD was 
calculated using Microsoft Office Excel 2003 software (Mi-
crosoft Corporation, Redmont, Washington, USA). Suscep-
tibility test results were considered when diameter for strains 
was within the ranges accepted by the National Committee 
for Clinical Laboratory Standard. 
RESULTS AND DISCUSSION 
The general microbiological quality of the infant food 
and feed samples is given in Table 1. The total counts varied 
over the range 1.0 to 6.4 log10 CFU/g with the mean total 
count of 3.4 log10 CFU/g. Of the eighty four samples exam-
ined, 60% were considered microbiologically satisfactory 
because the total aerobic mesophilic count were 4.0 log10 
CFU/g [18]. Nearly 10% (8) of the samples, were deemed 
unsatisfactory for infant consumption because they contained 
a total viable count of 5.0 log10 CFU/g powder. The total 
mould count in most samples was equal to or less than 3.7 
log10 CFU/ g. Average counts of Bacillus. spp, Staphylococ-
cus. spp and Enterobacteriaceae were 4.4, 4.5 and 3.8 log10 
CFU/g respectively.  
Occurrence of Bacillus spp. Enterobacteriaceae and 
Staphylococcus spp. in the samples was 61.9%, 27.4% and 
40.5% respectively. Of the 10 (60%) strains of Bacillus spp. 
were identified as Bacillus cereus. More than 64.3% of the 
samples contained high count of Bacillus spp. ( 2 log10 
CFU/g). Becker et al. [19] reported that when samples of 
infant food distributed in 17 countries were examined for B. 
cereus, 54% of them were contaminated with B. cereus with 
levels of  6 x 10
2
 viable cells/g, much lower than results 
found in this study. Dried milk products, such as milk pow-
der, infant milk formula and infant cereal products, contami-
nated with B. cereus should be considered as potential vehi-
cle for foodborne B.cereus disease [19, 20]. These products 
often contain high level of carbohydrates (starch, sucrose or 
lactose) and minerals which can promote proliferation and 
enterotoxin production when they are reconstituted and held 
at ambient temperature for extended periods, potentially 
even at refrigeration temperature [21-23]. Bacillus spp iso-
lated were identified as B. cereus, B. licheniformis, Geoba-
cillus stearothermophilus, B. subtilis, Brevi. Laterosporus 
and some unidentified Bacillus spp. isolated were similar to 
that reported by Rowan et al. [21]. 
In this study, it was found that more than 26.3% of the 
samples contained Enterobacteriaceae ( 2 log10 CFU/g). 
Salmonella was not present in any of the samples tested. 
Other studies showed occurrence of Enterobacteriaceae in 
different types of infant food products although Salmonella 
spp were not detected in any of the infant samples examined 
[8, 10, 24]. Iversen and Forsythe [9] also reported the ab-
sence of Salmonella. spp in powdered infant milk formula. 
Other pathogens such as Listeria monocytogenes and Salmo-
nella spp have been shown to be able to tolerate the spray 
drying, a process used in the production of a number of in-
fant food formulae [25]. Enterobacteriaceae isolates from the 
products examined were identified as K. pneumoniae, E. 
aerogenes, E. sakazakii, K. oxytoca, E. coli, Aeromonas hy-
drophila, E. cancerogenus. Two of the samples which 
showed the presence of E. sakazakii were both manufactured 
in North Africa. Occurrence of E. sakazakii in formula and 
infant feed has been reported [8, 26]. 
Over 42 % of the samples contained Staphylococcus spp 
( 2 log10 CFU/g). This is in agreement with the study by 
Benda and Vyletelova [27]. They reported that S. aureus 
counts from milk samples collected from a baby food factory 
were 2 to 3 log10 CFU/g. Also Silvia, et al. [28] reported 
isolating S. aureus from 11 samples of milk with counts 
greater than 10
5
 CFU/g. Sugimoto, et al. [29] investigated 
raw and powdered milk samples collected from various milk 
processing factories for microbial quality and found that vi-







 CFU/g in powdered samples. Staphylococcus 
aureus and B. cereus accounted for 79 and 26.3% of the iso-
lates respectively. They isolated 143 strains of S. aureus and 
13 (9.1%), 5 (3.5%) and 2 (1.4%) of the strains produced 
enterotoxins B, A and C respectively. Staphylococci are 
among the most significant pathogens that cause wide spec-
trum of diseases in both humans and animals. Staphylococ-
cus aureus is capable of producing enterotoxins which are 
resistant to most cooking temperature [30]. The toxin is only 





 cells/g or ml of contaminated foods (Leter-
tre, et al. [31]. The 27 isolated strains of Staphylococcus spp. 
were identified as Derma nishinomiyaen, S. xylosus, Kocuria 
varians, S. lentus, Kytococ sedenarius, and Kocuria rosea.  
Sixty isolates comprising Bacillus spp., Staphylococcus 
spp. and Enterobacteriaceae were identified by API system 
(Biomerieux Limited, Basingstoke, UK). All identified iso-
lates were tested for their resistance to antibiotics (Tables 2- 
4).  
Based on MIC break point analysis, a high percentage of 
bacterial resistance was observed among Gram positive bac-
teria with some of the antimicrobials tested. For instance 
80% of Bacillus spp. strains were resistant to cephalosporin 
(MIC  2.048
 
μg/ml), 60% of strains were resistant to peni-
cillin (MIC ranged 0.128-0.256 μg/ml), while 40% of strains 
were resistant to bacitracin (MIC ranged 0.128-1.024 μg/ml). 
Antibiotic susceptibility data with Bacillus spp. confirm pre-
vious reports that Gram positive bacteria are generally resis-
tant to penicillin and cephalosporin [32-34]. The majority of 
the Gram positive strains were found to be resistant to peni-
cillin, bacitracin and cephalosporin, probably in part by 
means of ß- lactamase production [34]. For other antimicro-
bial tested, the tetracycline MIC was 0.128 g/ml and gen-
tamicin MIC was 0.0002 μg/ml for Bacillus spp. 
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Table 2. Minimum Inhibitory Concentration (MIC) of Some Antibiotics for Bacillus spp. Isolated from Infant Foods 
MIC ( g/ml) 
b




Gentamicin Tetracycline Cephalosporin Bacitracin Penicillin 
Brevi. laterosporus 0.002 a / (22± 0.0) b 0.016 a / (21 ± 0.5) b - 0.032 b / (13± 0.3) b 0.064 a (18 ± 0.13) b 
Bacillus.spp  0.001 a / (23 ± 0.17) b - 2.048 a / (20 ± 0.44) b 0.512 a / (20± 0.0) b 0.00025 a (28 ± 0.1) b 
B. cereus (1)  0.002 a / (17 ± 0.0) b 0.016 a / (15± 0.1) b - 0.016 a / (1.5 ± 0.22)b 0.256 a / (15 ± 0. 1) b 
B. cereus (2)  0.002 a / (20 ± 0.1) b 0.016 a / (16 ± 0.0) b 2.048 a / (12 ± 0.1) b 0.008 a / (14 ± 0.0) b 0.128 a / (19 ± 0.0) b 
B. cereus (3)  0.002 a / (19 ± 0.2) b 0.128 a / (20 ± 0.1) b - 1.024 a / (16 ± 0.0) b 0.256 a (18 ± 0.0) b 
Geobacillus stearothermophilus 0.001 a / (15± 0.0) b 0.008 a / (16 ± 0.1) b 2.048 a / (16± 0.35) b 0.128 a / (15 ± 0.33) b 0.004 a (20± 0. 18) b 
B. cereus (4) 0.005 a / (15 ± 0.5) b 0.032 a / (16 ± 0.0) b - 0.032 a / (16 ± 0.0) b 0.256 a / (16 ± 0. 1) b 
B. cereus (5)  0.0002 a / (17 ± 0.0) b 0.016 a / (17 ± 0.3) b 2.048 a / (15 ± 0.0) b 0.032 a / (15± 0.1) b 0.128 a (18 ± 0. 1) b 
B. licheniformis 0.002 a / (19 ± 0.4) b 0.016 a / (16 ± 0.0) b - 0.004 a / (15 ± 0.0) b 0.256 a (19 ± 0. 2) b 
B. subtilis  0.0005 a / (18 ± 0.32) b 0.032 a / (20 ± 0.5) b 0.256 a / (26 ± 0.0) b 0.00025 a / (14 ± 0. 5)b 0.0002 a (32± 0.0) b 
B. cereus (6) 0.001 a / (16± 0.12) b 0.004 a / (19± 0.2) b 2.048 a / (18± 0.0) b 0.032 a / (15 ± 0.4) b 0.016 a / (15± 0. 3) b 
a=MIC ( g/ ml), b=Diameter Zone (mm ± SD), - = no effect. 
 
Table 3. Minimum Inhibitory Concentration (MIC) of some Antibiotics for Staphylococcus spp. and Micrococcus spp. Isolated 
from Infant Foods 
MIC ( g/ml) 
a




Gentamicin Tetracycline Cephalosporin Bacitracin Penicillin 
S. aureus (NCTC 6571)  0.002 a / (19 ± 0.4 ) b 0.016 a / (25 ± 0.0) b 0.512 a / (18 ± 1.02 ) b 0.064 a / (15 ± 0.0) b 0.004 a / (40 ± 0.76) b 
S. xylosus  0.0005 a / (16 ± 0.0) b 0.016 a / (21 ±0.3 ) b 0.512 a / (19 ± 0.0) b 0.256 a / ( 18 ± 0.54) b 0.064 a / (17 ± 0.57) b 
S. lentus  0.001 a / (15 ± 0.1) b 0.008 a / ( 24 ± 0.8 ) b 0.512 a / (22 ± 0.2 ) b 0.008 a / (21± 0.42 ) b 0.0002 a 5 / (23 ± 1.02) b 
Kytococ. Sedenarius  0.0005 a / (18 ± 0.5) b 0.002 a / (13 ± 0.0) b 0.512 a / (34 ± 0.7 ) b 0.0005 a (13 / ± 0.61 ) b 0.00025 a / (30 ± 0.9 ) b 
Derma.nishinomiyaen  0.0005 a / (16 ± 0.36) b 0.032 a / ( 21 ± 0.3) b 0.512 a / (26 ± 0.58 ) b 0.128 a / (25 ± 0.0 ) b 0.128 a / (20 ± 0.82 ) b 
Microccus. spp (1) 0.00025 a / (23 ± 0.5 ) b 0.008 a / (17 ± 0.0 ) b 0.512 a / (38 ± 0.24) b 0.512 a / (20 ± 0.5) b 0.004 a / (23 ± 0.01 ) b 
Microccus. spp (2) 0.001 a / (18 ± 0.6 ) b 0.032 a / ± (18 ± 0.59 ) b 0.512 a / ( 36 ± 0.53 )b 0.0002 5 a / (25 ± 0.54) b 0.0002 a / (33 ± 0.31) b 
Koc.varians / rosea (1) 0.002 a / (13 ± 0.67) b 0.032 a / ( 25 ± 0.53 ) b - 0.032 a / (21 ± 0.0 ) b 0.512 a / ( 23 ± 0.35) b 
Koc.varians / rosea (2) 0.004 a / (20 ± 0.2) b 0.016 a / ( 19 ± 0.4) b 0.512 a / (32 ± 0.42 ) b - - 
S. capitis  0.002 a / (21 ± 0.32 ) b 0.008 a / (15 ± 0.0 ) b - - 2.048 a / (15 ± 0.55 ) b 
a = MIC ( g/ ml) b = Diameter Zone (mm ± SD) - = no effect. 
 
Table 4. Minimum Inhibitory Concentration (MIC) of some Antibiotics for Enterobacteriaceae Isolated from Foods 
MIC ( g/ml)
 a




Gentamicin Tetracycline Cephalosporin Streptomycin Penicillin 
E. coli (NCTC 9001) 0.002 a / (20 ± 0.0) b 0.032 a / (23 ± 0.2) b 0.512 a / (22 ± 0.19) b 0.004 a / (18± 0. 1) b 0.128 a / (14 ± 0.0) b 
K. pneumoniae (1) 0.002 a / (19 ±0.0) b 0.032 a / (16 ± 0.11) b 0.256 a / (17 ± 0.0) b 0.008 a /(17 ± 0.01) b 0.256 a /15 ± 0.2) b 
K. pneumoniae (2) 0.002 a / (17 ± 0.24 ) b 0.064 a / (17 ± 0.0) b 0.512 a / (21± 0.2) b 0.004 a / (14± 0.0) b 0.256 a / (13 ± 0.1) b 
E. aerogenes 0.002 a / (17 ±0.33) b 0.128 a /( 19 ± 0.4 ) b - 0.008 a / (12 ± 0. 4) b 0.256 a / (18 ± 0.03) b 
E. sakazakii  0.002 a / (18 ± 0.0) b 0.128 a / ( 18 ± 0.13) b - 0.008 a / (16 ± 0. 5) b - 
Aero. hydrophila 0.002 a / (20 ± 0.15) b 0.032 a / (19 ± 0.2) b 0.128 a / (20 ± 0.36) b 0.008 a / (20 ± 0.14) b 0.064 a / (18 ± 0.18) b 
E. cancerogenus 0.0005 a / (16 ±0.5) b 0.004 a / (19 ± 0.0) b 0.128 a / (17 ± 0.0) b 0.004 a / (15 ± 0.22) b 0.0128 a / (19 ± 0.0) b 
K. oxytoca 0.004 a /(23 ± 0.23) b 0.004 a / (23 ± 0.3) b 0.032 a / (21±0.20) b 0.256 a /(23 ± 0.0) b 0.128 a / (19 ± 0.5) b 
a = MIC ( g/ ml), b = Diameter Zone (mm ± SD), - = no effect. 
Evaluation of Some Antibiotics Against Pathogenic Bacteria Isolated The Open Food Science Journal, 2008, Volume 2    99 



















 B. cereus  
 (5)  
B. licheni-
formis 
B. subtilis  
B. cereus 
(6)  
Penicillin G 10 
units 
9 (I) 29 (S) 8 (I) 10 (I) 0 (R) 10 (I) 9 (I) 8 (I) 7 (R) 10 (I) 12 (I) 
Streptomycin  
(10 g) 
22 (S) 26 (S) 21(S) 25 (S) 20 (S) 24 (S) 25 (S) 22 (S) 20 (S) 26 (S) 24 (S) 
Erythromycin  
(15 g) 
30 (S) 34 (S) 29 (S) 32 (S) 27 (S) 30 (S) 31 (S) 30 (S) 28 (S) 38 (S) 21(S) 
Ampicillin (10 g) 10 (R) 30 (S) 10 (R) 12 (I) 0 (R) 14 (I) 10 (R) 9 R) 10 (R) 30 (S) 12 (I) 
Cephalothin  
(30 g) 
16 (I) 49 (S) 14 (R) 14 (R) 18 (S) 17 (I) 15 (I) 14 (R) 14 (R) 46 (S) 17 (I) 
Chloramphenicol 
(30 g) 
25 (S) 37 (S) 25 (S) 24 (S) 8 (R) 34 (S) 35 (S) 24 (S) 21(I) 35 (S) 27 (S) 
Kanamycin  
(10 g) 
25 (S) 30 (S) 19 (S) 25 (S) 20 (S) 26 (S) 25 (S) 19 (S) 19 (S) 30 (S) 27 (S) 
Nalidixic acid  
(30 g) 
12 (R) 23 (S) 20 (S) 22 (S) 18 (I) 14 (I) 21(S) 19 (S) 17 (I) 21(S) 11(R) 
Bacitracin  
(10 units) 
11(R) 10 (R) 18 (S) 21 (S) 0 (R) 12 (R) 13 (R) 19 (S) 22 (S) 13(R) 9 (R) 
Tetracycline  
(30 g) 
27 (S) 21(S) 18 (I) 20 (S) 13 (R) 27 (S) 25 (S) 22 (S) 15 (I) 20 (S) 30 (S) 
Gentamicin  
(10 g) 
23 (S) 36 (S) 22 (S) 21 (S) 20 (S) 25 (S) 22 (S) 22 (S) 22 (S) 29 (S) 24 (S) 
R = Resistance, I = Intermediate, S= susceptible. 
 
Table 6. The Susceptibility of Staphylococcus spp. and Micrococcus spp. Isolated from Various Infant Foods to some Antibiotics 

























S. capitis  
Penicillin G 10 
units 
40 (S) 15 (I) 25 (S) 32 (S) 45 (S) 30 (S) 0 (R) 0 (R) 29 (S) 0 (R) 
Streptomycin  
(10 g) 
18 (S) 23 (S) 16 (S) 16 (S) 29 (S) 15 (S) 18 (S) 19 (S) 13 (I) 18 (S) 
Erythromycin  
(15 g) 
30 (S) 37 (S) 35 (S) 31(S) 45 (S) 35 (S) 10 (R) 13 (R) 28 (S) 0 (R) 
Ampicillin (10 g) 40 (S) 25 (S) 24 (S) 32 (S) 49 (S) 32 (S) 13 (I) 14 (I) 25 (S) 11(R) 
Cephalothin (30 g) 40 (S) 28 (S) 26 (S) 30 (S) 55 (S) 57 (S) 18 (S) 29(S) 25 (S) 6 (R) 
Chloramphenicol 
(30 g) 
30 (S) 19 (S) 36 (S) 52 (S) 42 (S) 3.8 (S) 28 (S) 18(S) 30 (S) 29 (S) 
Kanamycin (10 g) 24 (S) 30 (S) 29 (S) 32 (S) 38 (S) 30 (S) 25 (S) 20(S) 15 (S) 21(S) 
Nalidixic acid  
(30 g) 
30 (S) 17 (I) 19 (S) 25 (S) 30 (S) 24 (S) 21(S) 22(S) 0 (R) 20 (S) 
Bacitracin  
(10 units) 
24 (S) 13 (R) 19 (S) 13 (R) 24 (S) 12 (R) 0 (R) 0 (R) 21(S) 0 (R) 
Tetracycline  
(30 g) 
30 (S) 30 (S) 30 (S) 24 (S) 25 (S) 24 (S) 19 (S) 20(S) 24 (S) 20 (S) 
Gentamicin (10 g) 22 (S) 30 (S) 26 (S) 30 (S) 35 (S) 31 (S) 22 (S) 22(S) 19 (S) 20 (S) 
R = Resistance, I = Intermediate, S= susceptible. 
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Table 7. The Susceptibility of Enterobacteriaceae Isolated from Various Infant Foods to some Antibiotics 








































19 (S) 17 (S) 13 (I) 20 (S) 21(S) 21(S) 24 (S) 19 (S) 20 (S) 22 (S) 
Erythromycin 
(15 g) 
10 (R) 13 (R) 10 (R) 0 (R) 20 (I) 17 (I) 20 (I) 10 (R) 20 (I) 15 (I) 
Ampicillin  
(10 g) 
8 (R) 10 (R) 18 (S) 5 (R) 18 (S) 25 (S) 20 (S) 22 (S) 18 (S) 25 (S) 
Cephalothin  
(30 g) 
25 (S) 0 (R) 16 (I) 0 (R) 30 (S) 21(S) 17 (I) 20 (S) 23 (S) 20 (S) 
Chlorampheni-
col (30 g) 
29 (S) 26 (S) 25 (S) 25 (S) 29 (S) 33 (S) 25 (S) 29 (S) 30 (S) 35 (S) 
Kanamycin  
(10 g) 
23 (S) 21(S) 24 (S) 22 (S) 21(S) 23 (S) 24 (S) 22 (S) 25 (S) 22 (S) 
Nalidixic acid 
(30 g) 
23 (S) 21(S) 13 (R) 23 (S) 27(S) 20 (S) 23 (S) 20 (S) 27 (S) 30 (S) 
Bacitracin  
(10 units) 
6 (R) 0 (R) 6 (R) 6 (R) 7 (R) 0 (R) 0 (R) 0 (R) 0 (R) 0 (R) 
Tetracycline  
(30 g) 
22 (S) 19 (S) 21(S) 23 (S) 23 (S) 34 (S) 26 (S) 22 (S) 25 (S) 38 (S) 
Gentamicin  
(10 g) 
22 (S) 20 (S) 23 (S) 24 (S) 25 (S) 29 (S) 25 (S) 23 (S) 25 (S) 30 (S) 
R = Resistance, I = Intermediate, S= susceptible. 
Antibiotic resistance profiles of the isolates are shown in 
Tables 5 to 7. The percentage resistance of Enterobacte-
riaceae was 100% with bacitracin, 50% erythromycin and 
penicillin, 30% ampicillin, 20% cephalosporin and 10% 
nalidixine acid. Cameiro et al. [35] reported that 33% of En-
terobacteriaceae isolated from 18 infant formula samples 
were resistance to ampicillin, amoxicillin/ clavulanic acid, 
cefoxitin and cephalotin. The percentage resistance of Bacil-
lus spp was 54.5% ampicillin, 63.6% bacitracin, 36.4% 
cephalosporin, while 18.2% was resistant to penicillin and 
nalidixic acid (Table 5). The percentage resistance by 
Staphylococcus spp. was 60% bacitracin and 30% penicillin 
and erythromycin (Table 6). The typed strain was susceptible 
to all antibiotics tested. Antibiotic resistance among the En-
terobacteriaceae family varied (Table 7). Enterobacteriaceae, 
Staphylococcus spp. and Bacillus spp. strains were highly 
susceptible (100%) to chloramphenicol, kanamycin, gen-
tamicin and streptomycin. These results indicate that there is 
a considerable variation in susceptibility depending on the 
species. In most cases there were some antibiotics such as 
tetracycline, gentamicin, kanamycin and nalidixine acid 
which were highly active against Bacillus spp., Staphylococ-
cus spp. and also active against Enterobacteriaceae.  
CONCLUSION 
Bacterial contamination is of the major concern since 
they tend to proliferate once a feed in reconstituted with wa-
ter under warm environmental conditions. Also most isolated 
strains were resistance to some antibiotic agents such as 
cephalosporin, bacitracin and penicillin. Many of the locally 
produced infant foods investigated in this study are still pro-
duced by small to medium scale manufacturers whose prem-
ises, food processing and quality of ingredients may lack a 
thorough food safety protocol and quality assurance systems 
in the preparation and/or manufacture of these infant foods. 
Application of Hazard Analysis Critical Control Point 
(HACCP) system in the manufacturing processes would im-
prove the quality of such products. An important aspect of 
the study, yet to be undertaken, is the mycological profile 
and presence of mycotoxins in the infant food especially 
when stored under simulated environmental conditions. 
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